This market resolves to Yes if by December 31, 2026, a major pharmaceutical company publicly announces the development of a new drug that involved the use of quantum chemistry software such as EXESS in its design or discovery. Confirmation must come from a press release or an equivalent formal announcement from the company.
Comments & Analysis
Quantum chemistry software is advancing quickly, but the technology is still not mature enough to reliably produce a marketable drug within such a short period of time. Plus with everyone focused on ai, I would bet against an innovation like this in this sector by this year. I think some quantum advantage system would emerge (what experts say), but a full, fault tolerant system is unlikely.
Rationale:The comment provides a well-reasoned analysis of the current state of quantum chemistry software and its potential impact on drug development. It accurately notes the rapid advancement of the technology while acknowledging its current limitations, which aligns with expert opinions. The argument is logically sound and directly addresses the market question, with minimal emotional appeal.